Qinglai Lu
CIK: 0002127285
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INDP
Indaptus Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Lu Qinglai
Lu Qinglai (SEC CIK 0002127285) files insider reports with the SEC as Director of Indaptus Therapeutics, Inc. (INDP).
Signal8 holds 1 ownership filing by Lu Qinglai, a Form 3, filed on Apr 20, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Lu Qinglai's filings is in NEW YORK, NY.
Other insiders filing for Indaptus Therapeutics, Inc. (INDP)
- Yao Yun, 10% Owner
- SINO LION VENTURES Ltd, 10% Owner
- Dai Junyi, Chief Executive Officer
- Lazar David E., Director
- Jabbour Jerome D, Director
- McMurdo Matthew Charles, Director